Form 4 for CRVL CORVEL CORP
Accepted 2024-02-09 00:00:00 ET · period of report 2024-02-07 · accession 0000899243-24-000168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-02-09 | 2024-02-08+ | CRVL | HAMERSLAG STEVEN J | Dir | S - Sale+OE | $239.82 | -4,921 | 115.2K | -4% | -$1.18M |
| DM | 2024-02-09 | 2024-02-07 | CRVL | HAMERSLAG STEVEN J | Dir | M - OptEx | $68.98 | +7,000 | 7,000 | New | +$482.9K |
| D | 2024-02-09 | 2024-02-07 | CRVL | HAMERSLAG STEVEN J | Dir | F - Tax | $232.26 | -2,079 | 4,921 | -30% | -$482.9K |
| DI | 2024-02-09 | 2024-02-07 | CRVL | HAMERSLAG STEVEN J | Dir | G - Gift | $0.00 | +4,921 | 116.4K | +4% | $0 |
| D | 2024-02-09 | 2024-02-07 | CRVL | HAMERSLAG STEVEN J | Dir | G - Gift | $0.00 | -4,921 | 0 | -100% | $0 |
| DM | 2024-02-09 | 2024-02-07 | CRVL | HAMERSLAG STEVEN J | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-09 | S | D | 290 | $242.32 | 111,468 | I | — | — | (F13) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $242.05 to $242.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-02-07 | M | A | 1,000 | $48.35 | 1,000 | D See Footnote | — | — | (F1) Reflects the exercise of stock options awarded to the Reporting Person on August 3, 2017. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 3 | Common | Common Stock | 2024-02-09 | S | D | 430 | $241.42 | 111,758 | I | — | — | (F12) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $241.03 to $241.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-02-07 | M | A | 3,000 | $57.35 | 4,000 | D See Footnote | — | — | (F2) Reflects the exercise of stock options awarded to the Reporting Person on August 2, 2018. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 5 | Common | Common Stock | 2024-02-07 | M | A | 3,000 | $87.49 | 7,000 | D See Footnote | — | — | (F3) Reflects the exercise of stock options awarded to the Reporting Person on August 8, 2019. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 6 | Common | Common Stock | 2024-02-07 | F | D | 2,079 | $232.26 | 4,921 | D See Footnote | — | — | (F4) Reflects shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), withheld by the Issuer to cover the Reporting Person's exercise price of the stock options reported herein. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 7 | Common | Common Stock | 2024-02-09 | S | D | 255 | $240.27 | 112,188 | I | — | — | (F11) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2024-02-09 | S | D | 1,019 | $239.52 | 112,443 | I | — | — | (F10) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.01 to $239.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2024-02-09 | S | D | 927 | $238.21 | 113,462 | I | — | — | (F9) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $238.00 to $238.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2024-02-08 | S | D | 808 | $240.36 | 114,389 | I See Footnote | — | — | (F8) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 11 | Common | Common Stock | 2024-02-08 | S | D | 1,192 | $239.67 | 115,197 | I See Footnote | — | — | (F7) Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.39 to $239.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 12 | Common | Common Stock | 2024-02-07 | G | A | 4,921 | $0.00 | 116,389 | I See Footnote | — | — | (F5) On February 7, 2024, the Reporting Person made a bona fide gift of 4,921 shares of Common Stock to the Steven J. Hamerslag and Jean Wells Hamerslag Trust Dtd. 12/09/88 (the "Hamerslag Trust"), of which the Reporting Person is a trustee. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 13 | Common | Common Stock | 2024-02-07 | G | D | 4,921 | $0.00 | 0 | D See Footnote | — | — | (F5) On February 7, 2024, the Reporting Person made a bona fide gift of 4,921 shares of Common Stock to the Steven J. Hamerslag and Jean Wells Hamerslag Trust Dtd. 12/09/88 (the "Hamerslag Trust"), of which the Reporting Person is a trustee. (F6) The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust. |
| 14 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-07 | M | D | 3,000 | $0.00 | 0 | D | $87.49 · — to 2029-08-08 | 3,000 Common Stock | (F3) Reflects the exercise of stock options awarded to the Reporting Person on August 8, 2019. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. |
| 15 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-07 | M | D | 3,000 | $0.00 | 0 | D | $57.35 · — to 2028-08-02 | 3,000 Common Stock | (F2) Reflects the exercise of stock options awarded to the Reporting Person on August 2, 2018. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. |
| 16 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-02-07 | M | D | 1,000 | $0.00 | 0 | D | $48.35 · — to 2027-08-03 | 1,000 Common Stock | (F1) Reflects the exercise of stock options awarded to the Reporting Person on August 3, 2017. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date. |